Categories Analysis, Technology, U.S. Markets News

Earnings preview: BFSI to be the deciding factor for Infosys in Q3

Bengaluru-based IT giant Infosys (INFY) is scheduled to report third-quarter results on Friday, January 11, before the market opens. Analysts expect the company to post earnings of 13 cents per share against revenue of $2.95 billion.

INFY shares have gained 18% in the trailing 52-weeks period. However, after hitting a peak of $10.61 in September, shares have declined 8%.

Analysts expect the solid growth in US business as well as depreciation of Rupee to boost growth in an otherwise seasonally weak quarter. Currency fluctuation is also expected to lift margins by 40bps to 60bps on a quarter-over-quarter basis.

Infosys office canary wharf
Courtesy: Infosys

 

Meanwhile, all eyes will be on the BFSI (Banking, financial services, and insurance) segment, especially after weakness in the first quarter. Though it has picked up since, thanks to a lot of effort going into the regulatory side, investors will be looking forward to any insights that the management has to offer.

Also, most brokerages expect the company to keep its outlook unchanged.

In a statement to stock exchanges on Tuesday, Infosys said it would consider proposals for share buybacks and a special dividend during its board meeting to be held on January 11. Any announcements in this regard will be made along with the Q3 results.

Infosys posts in line Q2 profit

During the prior sequential quarter, Infosys reported a marginal rise in earnings helped by higher revenue and better cost management. Net profit rose 0.5% to $581 million, in line with analysts’ expectations. Meanwhile, revenue grew 7.1% to $2.92 billion.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference, and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top